This site is intended for healthcare professionals
Clinical trials
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • A 26 week, randomized, double-blind, parallel-grou...
Clinical trial

A 26 week, randomized, double-blind, parallel-group, active controlled, multicenter, multinational safety study evaluating the risk of serious asthma-related events during treatment with Symbicort�, a fixed combination of inhaled corticosteroid (ICS) (bud

Read time: 1 mins
Last updated:8th Jan 2013
To evaluate the risk of serious asthma related events during treatment with Symbicort pMDI or budesonide pMDI alone (asthma-related deaths, intubations, hospitalizations).
Category Value
Study start date 2013-01-08

View full details